Imaging Cell Line

  • Hela/HSV1-tk-firefly luciferase (CMV)  stable cells
    Hela/HSV1-tk-firefly luciferase (CMV) stable cells
    Hela, a human cervix adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. Hela/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $2,350.00
  • Hela/RFP (CMV)  stable cells
    Hela/RFP (CMV) stable cells
    Hela, a human cervix adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. Hela/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $1,350.00
  • Hela/RFP-firefly luciferase (CMV)  stable cells
    Hela/RFP-firefly luciferase (CMV) stable cells
    Hela, a human cervix adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. Hela/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The cells proliferation and trafficing could be imaged with fluorescence imaging in xenograft model.
    Price: $2,350.00
  • Hela/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    Hela/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells
    Hela, a human cervix adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. Hela/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • Hela/TGF-β Reporter stable cells
    Hela/TGF-β Reporter stable cells - CLONED
    Hela/TGF-β Reporter stable cells has been widely used in cancer research and drug development in vitro and in vivo. Hela/TGF-β Reporter stable cells express transgenically firefly luciferase under the control of Smad3/4-binding elements (SBE) promoter.  The firefly luciferase expression is under control of TGF-β-induced Smad signaling.
    Price: $2,350.00
  • HepG2/firefly luciferase (CMV)  stable cells
    HepG2/firefly luciferase (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.
    Price: $1,800.00
  • HepG2/GFP-firefly luciferase (CMV)  stable cells
    HepG2/GFP-firefly luciferase (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter.
    Price: $2,800.00
  • HepG2/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    HepG2/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/GFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically GFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,800.00
  • HepG2/HSV1-tk (CMV)  stable cells
    HepG2/HSV1-tk (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $1,800.00
  • HepG2/HSV1-tk-firefly luciferase (CMV)  stable cells
    HepG2/HSV1-tk-firefly luciferase (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $2,800.00
  • HepG2/RFP (CMV)  stable cells
    HepG2/RFP (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $1,800.00
  • HepG2/RFP-firefly luciferase (CMV)  stable cells
    HepG2/RFP-firefly luciferase (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The cells proliferation and trafficing could be imaged with fluorescence imaging in xenograft model.
    Price: $2,800.00
  • HepG2/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    HepG2/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells
    HepG2, a human Heptocellular carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HepG2/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,800.00
  • HL60/firefly luciferase (CMV)  stable cells
    HL60/firefly luciferase (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.
    Price: $3,800.00
  • HL60/GFP (CMV)  stable cells
    HL60/GFP stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/GFP (CMV) stable cells express transgenically GFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $3,800.00
  • HL60/GFP-firefly luciferase (CMV)  stable cells
    HL60/GFP-firefly luciferase (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/GFP-firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $4,800.00
  • HL60/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    HL60/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $5,800.00
  • HL60/HSV1-tk (CMV)  stable cells
    HL60/HSV1-tk (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $3,800.00
  • HL60/HSV1-tk-firefly luciferase (CMV)  stable cells
    HL60/HSV1-tk-firefly luciferase (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $4,800.00
  • HL60/RFP (CMV)  stable cells
    HL60/RFP (CMV) stable cells
    HL60 cell line, promyelobast derived from human promyelocytic leukemia, has been widely used in cancer research and drug development in vitro and in vivo. HL60/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $3,800.00
Loading...